Trial: 201704120

A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity

Phase

II

Principal Investigator

Van Tine, Brian

Disease Site

Kaposi’s Sarcoma; Soft Tissue

Learn more about this study at: clinicaltrials.gov